Neo-adjuvant Chemotherapy

DRUG4 trials

Sponsors

Medical University of South Carolina, Hoffmann-La Roche, The First Hospital of Jilin University, Dr Kundan Singh Chufal

Conditions

Adenocarcinoma of Head of PancreasBreast CancerBreast Neoplasm FemaleEsophageal Neoplasm

Phase 2

Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma

TerminatedNCT01677988

Medical University of South CarolinaAdenocarcinoma of Head of Pancreas

Start: 2012-07-31Updated: 2016-01-15

Phase 3

A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

CompletedNCT01964391

Hoffmann-La RocheBreast Cancer

Start: 2014-02-21End: 2018-11-25Updated: 2019-04-02

Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer

The First Hospital of Jilin UniversityBreast Neoplasm Female

Start: 2016-12-31End: 2025-02-28Target: 1588Updated: 2017-01-10

Unknown Phase

Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning

Dr Kundan Singh ChufalEsophageal Neoplasm

Start: 2020-01-16End: 2023-07-31Target: 150Updated: 2022-12-28